Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)
Condition(s):Arthritis; RheumatoidLast Updated:February 23, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Arthritis; RheumatoidLast Updated:February 23, 2017Completed
Condition(s):PsoriasisLast Updated:July 25, 2014Completed
Condition(s):Lung Injury, Acute; Respiratory Distress Syndrome, Adult; Bronchiolitis ObliteransLast Updated:December 3, 2015Completed
Condition(s):Spondylitis, AnkylosingLast Updated:September 12, 2011Completed
Condition(s):Rheumatoid Arthritis; Axial SpondyloarthritisLast Updated:February 5, 2021Completed
Condition(s):PsoriasisLast Updated:December 2, 2016Completed
Condition(s):Psoriasis; Psoriatic Arthritis; Psoriatic NailLast Updated:January 6, 2022Unknown status
Condition(s):Spondylitis, Ankylosing; RecurrenceLast Updated:November 16, 2016Completed
Condition(s):Plaque PsoriasisLast Updated:June 28, 2019Completed
Condition(s):Mucocutaneous Lymph Node Syndrome; Kawasaki DiseaseLast Updated:May 6, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.